Searchable abstracts of presentations at key conferences in endocrinology

ea0063gp238 | Anterior and Posterior Pituitary | ECE2019

Immune checkpoint inhibitors therapy-induced hypophysitis is frequently associated with previous thyroid disorders: results from ImmuCare study

Levy Manon , Abeillon Juliette , Borson-Chazot Francoise , Dalle Stephane , Raverot Gerald , Cugnet-Anceau Christine

Context: The immune checkpoint inhibitor (ICI) therapy is frequently used to treat advanced cancers. Autoimmune adverse events have been reported, such as endocrine side effects including frequent thyroid disorders and more rarely hypophysitis. The aim of this study was to describe retrospectively the association thyroiditis-hypophysitis.Patients and method: From 99 patients with endocrine side effects of the ImmuCare cohort, 18 patients with hypophysiti...

ea0063p201 | Diabetes, Obesity and Metabolism 1 | ECE2019

Acquired generalized lipodystrophy: a new cause of Anti-PD-1 immune-related diabetes

Anceau Christine Cugnet , Jehl Alexandre , Vigouroux Corinne , Dalle Stephane , Harou Olivier , Marchand Lucien , Lascols Olivier , Caussy Cyrielle , Thivolet Charles , Laville Martine , Disse Emmanuel

Context: Anti-programmed cell death-1 (Anti-PD-1) antibodies have revolutionized advanced cancer therapy. Anti-PD1 therapy is responsible for immune-related adverse events, with frequent endocrine manifestations. Acquired generalized lipodystrophy (AGL), is a rare disease, thought to be immune-mediated, characterized by loss of adipose tissue and insulin resistance-associated complications. We describe the first case of AGL induced by immune checkpoint therapy.<p class="ab...